Handl HL - Search Results

1

Use of PD-1 and PD-L1 inhibitors after first-line therapy in esophageal cancer patients in the US.

Allaire JC, Balk M, Azmi S, Handl HL, Yang K, Barnes G. Allaire JC, et al. Among authors: handl hl. Curr Med Res Opin. 2021 Aug;37(8):1403-1407. doi: 10.1080/03007995.2021.1929134. Epub 2021 Jun 3. Curr Med Res Opin. 2021. PMID: 33989092 Free article.

2

Immunobiological aspects of therapeutic antibodies and related characterization approaches.

Liu PM, Handl H, Zou L, Kim B. Liu PM, et al. Curr Opin Drug Discov Devel. 2007 Sep;10(5):515-22. Curr Opin Drug Discov Devel. 2007. PMID: 17786849 Review.

3

Cell-specific targeting by heterobivalent ligands.

Josan JS, Handl HL, Sankaranarayanan R, Xu L, Lynch RM, Vagner J, Mash EA, Hruby VJ, Gillies RJ. Josan JS, et al. Among authors: handl hl. Bioconjug Chem. 2011 Jul 20;22(7):1270-8. doi: 10.1021/bc1004284. Epub 2011 Jun 16. Bioconjug Chem. 2011. PMID: 21639139 Free PMC article.

4

Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors.

Josan JS, Vagner J, Handl HL, Sankaranarayanan R, Gillies RJ, Hruby VJ. Josan JS, et al. Among authors: handl hl. Int J Pept Res Ther. 2008 Dec;14(4):293-300. doi: 10.1007/s10989-008-9150-3. Int J Pept Res Ther. 2008. PMID: 19714261 Free PMC article.

5

Heterobivalent ligands crosslink multiple cell-surface receptors--a step towards personal medicine.

Josan JS, Sankaranarayanan R, Handl HL, Fernandes S, Xu L, Vagner J, Gillies RJ, Hruby VJ. Josan JS, et al. Among authors: handl hl. Adv Exp Med Biol. 2009;611:413-4. doi: 10.1007/978-0-387-73657-0_178. Adv Exp Med Biol. 2009. PMID: 19400245 No abstract available.

6

Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors.

Vagner J, Xu L, Handl HL, Josan JS, Morse DL, Mash EA, Gillies RJ, Hruby VJ. Vagner J, et al. Among authors: handl hl. Angew Chem Int Ed Engl. 2008;47(9):1685-8. doi: 10.1002/anie.200702770. Angew Chem Int Ed Engl. 2008. PMID: 18205159 Free PMC article. No abstract available.

7

Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).

Handl HL, Sankaranarayanan R, Josan JS, Vagner J, Mash EA, Gillies RJ, Hruby VJ. Handl HL, et al. Bioconjug Chem. 2007 Jul-Aug;18(4):1101-9. doi: 10.1021/bc0603642. Epub 2007 Jun 26. Bioconjug Chem. 2007. PMID: 17591746 Free PMC article.

8

Rigid linkers for bioactive peptides.

Vagner J, Handl HL, Monguchi Y, Jana U, Begay LJ, Mash EA, Hruby VJ, Gillies RJ. Vagner J, et al. Among authors: handl hl. Bioconjug Chem. 2006 Nov-Dec;17(6):1545-50. doi: 10.1021/bc060154p. Bioconjug Chem. 2006. PMID: 17105235 Free PMC article.

9

Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor.

Handl HL, Vagner J, Yamamura HI, Hruby VJ, Gillies RJ. Handl HL, et al. Anal Biochem. 2005 Aug 15;343(2):299-307. doi: 10.1016/j.ab.2005.05.040. Anal Biochem. 2005. PMID: 16004955

10

Lanthanide-based luminescent assays for ligand-receptor interactions.

Handl HL, Gillies RJ. Handl HL, et al. Life Sci. 2005 Jun 10;77(4):361-71. doi: 10.1016/j.lfs.2005.01.009. Epub 2005 Feb 19. Life Sci. 2005. PMID: 15894006 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters